Use of costly breast cancer therapy strongly influenced by reimbursement policy
Thursday, April 28, 2011 - 09:30
in Health & Medicine
What Medicare would pay for and where a radiation oncologist practiced were two factors that strongly influenced the choice of intensity-modulated radiation therapy (IMRT) for treating breast cancer, according to an article published April 29 online in the Journal of the National Cancer Institute. The use of IMRT and the cost of radiation therapy increased sharply over the period of the study.